BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Costa A, Lo Barco T, Spezia E, Conti V, Roli L, Marini L, Minghetti S, Caramaschi E, Pietrangelo L, Pecoraro L, D’achille F, Accorsi P, Trenti T, Melani F, Marini C, Guerrini R, Darra F, Bergonzini P, Biagini G. Prospective Evaluation of Ghrelin and Des-Acyl Ghrelin Plasma Levels in Children with Newly Diagnosed Epilepsy: Evidence for Reduced Ghrelin-to-Des-Acyl Ghrelin Ratio in Generalized Epilepsies. JPM 2022;12:527. [DOI: 10.3390/jpm12040527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Senn L, Costa AM, Avallone R, Socała K, Wlaź P, Biagini G. Is the peroxisome proliferator-activated receptor gamma a putative target for epilepsy treatment? Current evidence and future perspectives. Pharmacol Ther 2023;241:108316. [PMID: 36436690 DOI: 10.1016/j.pharmthera.2022.108316] [Reference Citation Analysis]
2 Sarkisova K, van Luijtelaar G. The impact of early-life environment on absence epilepsy and neuropsychiatric comorbidities. IBRO Neuroscience Reports 2022;13:436-468. [DOI: 10.1016/j.ibneur.2022.10.012] [Reference Citation Analysis]
3 Pisani F, Spagnoli C. EEG in neonatal seizures: where to look and what to see. Expert Rev Neurother 2022;22:963-79. [PMID: 36637240 DOI: 10.1080/14737175.2022.2169132] [Reference Citation Analysis]
4 Costa A, Russo F, Senn L, Ibatici D, Cannazza G, Biagini G. Antiseizure Effects of Cannabidiol Leading to Increased Peroxisome Proliferator-Activated Receptor Gamma Levels in the Hippocampal CA3 Subfield of Epileptic Rats. Pharmaceuticals 2022;15:495. [DOI: 10.3390/ph15050495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]